Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Schmidt

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Pharmaceutical Research|October 2, 1998
Correction for non-ideal tracer pharmacokinetic disposition by disposition decomposition analysis (DDA)P Veng-Pedersen, S S Hong, J A Widness, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2004
Pharmacokinetic/pharmacodynamic analysis of paradoxal regulation of erythropoietin production in acute anemiaN H Al-Huniti, J A Widness, R L Schmidt, et al.
Biopharmaceutics & Drug Disposition|November 6, 2004
Erythropoietin production rate in phlebotomy-induced acute anemiaN H Al-Huniti, J A Widness, R L Schmidt, et al.
The American Journal of Physiology|January 22, 1998
Intravenous iron supplementation effect on tissue iron and hemoproteins in chronically phlebotomized lambsS F Guiang, M K Georgieff, D J Lambert, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1992
A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studiesJ A Widness, R L Schmidt, P Veng-Pedersen, et al.
International Journal of Laboratory Hematology|April 22, 2008
The effect of anticoagulant, storage temperature and dilution on cord blood hematology parameters over timeK J Freise, R L Schmidt, E L Gingerich, et al.
The American Journal of Physiology|March 1, 1992
Fetal iron and cytochrome c status after intrauterine hypoxemia and erythropoietin administrationM K Georgieff, R L Schmidt, M M Mills, et al.
Biopharmaceutics & Drug Disposition|August 10, 1999
A comparison of nonlinear pharmacokinetics of erythropoietin in sheep and humansP Veng-Pedersen, J A Widness, L M Pereira, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Developmental differences in erythropoietin pharmacokinetics: increased clearance and distribution in fetal and neonatal sheepJ A Widness, P Veng-Pedersen, N B Modi, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1996
Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effectsJ A Widness, P Veng-Pedersen, C Peters, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Pharmaceutical Research|October 2, 1998
Correction for non-ideal tracer pharmacokinetic disposition by disposition decomposition analysis (DDA)P Veng-Pedersen, S S Hong, J A Widness, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 28, 2004
Pharmacokinetic/pharmacodynamic analysis of paradoxal regulation of erythropoietin production in acute anemiaN H Al-Huniti, J A Widness, R L Schmidt, et al.
Biopharmaceutics & Drug Disposition|November 6, 2004
Erythropoietin production rate in phlebotomy-induced acute anemiaN H Al-Huniti, J A Widness, R L Schmidt, et al.
The American Journal of Physiology|January 22, 1998
Intravenous iron supplementation effect on tissue iron and hemoproteins in chronically phlebotomized lambsS F Guiang, M K Georgieff, D J Lambert, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1992
A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studiesJ A Widness, R L Schmidt, P Veng-Pedersen, et al.
International Journal of Laboratory Hematology|April 22, 2008
The effect of anticoagulant, storage temperature and dilution on cord blood hematology parameters over timeK J Freise, R L Schmidt, E L Gingerich, et al.
The American Journal of Physiology|March 1, 1992
Fetal iron and cytochrome c status after intrauterine hypoxemia and erythropoietin administrationM K Georgieff, R L Schmidt, M M Mills, et al.
Biopharmaceutics & Drug Disposition|August 10, 1999
A comparison of nonlinear pharmacokinetics of erythropoietin in sheep and humansP Veng-Pedersen, J A Widness, L M Pereira, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1992
Developmental differences in erythropoietin pharmacokinetics: increased clearance and distribution in fetal and neonatal sheepJ A Widness, P Veng-Pedersen, N B Modi, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 1, 1996
Erythropoietin pharmacokinetics in premature infants: developmental, nonlinearity, and treatment effectsJ A Widness, P Veng-Pedersen, C Peters, et al.
Pageof 5